RNU7-130P

Across TCGA pan-cancer cohorts, RNU7-130P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU7-130P data layer.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher RNU7-130P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU7-130P expression acts as an unfavorable survival marker, although some lineages such as LAML and BRCA show a favorable association.

LAML, LUAD, and PAAD are the cancer types where RNU7-130P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Quartile	All	0.671	0.374	.001	42	view →
LUAD	OS	Tertile	II,III,IV	0.307	0.605	.012	36	view →
PAAD	DFS	Tertile	All	0.100	0.505	.004	27	view →
CHOL	DFS	Tertile	All	0.037	0.486	.001	18	view →
KICH	DFS	Tertile	All	0.121	0.867	.023	15	view →
PRAD	OS	Tertile	All	0.967	0.995	.009	12	view →
ACC	DFS	Tertile	All	0.149	0.594	.043	9	view →
BRCA	OS	Tertile	II,III,IV	0.973	0.549	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU7-130P–LAML (DFS)

Open the LAML breakdown →